Ecosystem News
-
Italian Healthcare Holding Acquires Majority Stake in GetSet Surgical
Milan-based Demetra Holding acquires a 51% stake in GetSet Surgical, a leader in sterile packaged single-use spine surgical kits founded in 2016. The strategic acquisition…
startupticker.ch
-
Startups unlock global success through accelerator programs
Joining an accelerator program offers several benefits, including access to industry players and experts, as well as training designed to help companies advance their solutions.…
startupticker.ch
-
€2.85 million to accelerate AI in drug discovery
Lugano-based InVirtuoLabs aims to halve development time and costs in pharmaceutical research using artificial intelligence and advanced molecular simulations. The startup has now closed its…
startupticker.ch
-
Oculis raises USD 100 million
Nasdaq-listed biotech company Oculis announced the pricing of an underwritten offering of 5,000,000 of its ordinary shares at a price of $20.00 per share, for…
startupticker.ch
-
vVARDIS secures USD 35 million to accelerate global growth
vVARDIS, a Swiss high growth dental company, and OrbiMed, a leading healthcare investment firm, today announced the closing of a $35 million financing. The capital…
startupticker.ch
-
BioVersys Opens IPO Season at SIX Swiss Exchange
Today, BioVersys, a leading Swiss biotech company specializing in novel antibacterial products for serious life-threatening infections, listed its shares at SIX Swiss Exchange. At an…
startupticker.ch
-
CHF 2.4 billion for Swiss start-ups
Investment in knowledge-based start-ups fell again in 2024, by 8.5% compared with the previous year. The number of financing rounds also fell for the first…
startupticker.ch
-
Frank Thelen invests in Akina’s CHF 2.8 million seed round
Through its investment in Akina, Freigeist Capital, the Deep Tech VC founded by Frank Thelen, has led its first investment in the healthtech sector. The…
startupticker.ch
-
Start-up boom thriving at ETH Zurich
Once again, around 40 spin-off companies were launched at ETH Zurich. Start-ups in the fields of artificial intelligence and biotechnology were particularly well represented.
startupticker.ch
-
BioVersys to go public next week
BioVersys started the offer period of its newly issued shares. Based on the offer price, the implied market capitalization of BioVersys is about CHF 212.9…
startupticker.ch
-
AB2 Bio signs USD 600 million agreement with Nippon Shinyaku
AB2 Bio Ltd., developing therapies for the treatment of severe systemic hyperinflammatory diseases and conditions driven by IL-18, has entered into an option and licensing…
startupticker.ch
-
BioVersys to go public at SIX Swiss Exchange
BioVersys develops novel antibacterial products for serious life-threatening infections caused by multidrug-resistant bacteria. The Basel-based company plans to conduct an initial public offering on the…
startupticker.ch